Post-earnings recap
Reported
Thu, Aug 1, 2013
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
ResMed's earnings report shows a positive surprise in EPS, which contributed to a 1.53% increase in stock price. The lack of revenue figures and guidance may leave some investors cautious, but the EPS beat suggests solid performance. Overall, the company remains focused on growth despite not providing detailed financial forecasts.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.62 | N/A | +1.31% |
| Revenue | N/A | N/A | N/A |
Management expressed satisfaction with the EPS results, indicating a commitment to long-term growth. However, they did not provide specific revenue figures or guidance.
We are pleased with our EPS performance this quarter.
While we did not provide specific revenue figures, we remain focused on our long-term growth strategy.